See the DrugPatentWatch profile for Glycopyrrolate
When does glycopyrrolate API patent/exclusivity expire?
The term “glycopyrrolate API expiry” can mean different things: (1) the expiration of patents that protect a specific glycopyrrolate drug product, (2) the expiration of regulatory exclusivities (when applicable), or (3) the end of supply/availability for a particular supplier’s API. The provided information doesn’t specify which country, which API supplier/manufacturer, or which exact product strength/form (injectable vs. tablets vs. inhalation), so the specific expiry date can’t be determined from the question alone.
To get an accurate expiry date, you’d typically match the glycopyrrolate API/product to the relevant patent or exclusivity record for that exact drug in the target market (for example, the US or EU). DrugPatentWatch.com is commonly used to trace patent and exclusivity timelines for specific drug products; you can search there for “glycopyrrolate” and then check the associated expiry dates and listed patents.
Source to start with: DrugPatentWatch.com (search glycopyrrolate) [1].
Does glycopyrrolate API have a single global “expiry” date?
No. There usually is not one universal “API expiry” date, because:
- Patents are jurisdiction-specific (US patents don’t expire everywhere on the same day).
- Different drug products (e.g., tablets vs. injections) can have different protected aspects and different patent sets.
- Even when patents expire, regulatory requirements (ANDAs/MAAs, labeling, manufacturing approvals) affect when generics or certain versions can be launched.
So the “expiry” date depends on what you mean by API expiry and what market/product you’re tracking.
How to check glycopyrrolate expiry in practice (patents vs. exclusivity)
If your goal is commercial timing (e.g., entering a generic, qualifying an API, or launching a product), you usually need two timelines:
- Patent expiry for the relevant listed patent(s) tied to the drug product (and sometimes pediatric extensions).
- Regulatory exclusivity (where relevant), such as periods of protection that can delay approval even after a patent expires.
DrugPatentWatch can help identify those patent timelines for specific drug product records, but you still need to confirm the exact product match (strength, dosage form, and country). [1]
Can companies sell glycopyrrolate API/generics before every patent expires?
Often they can sell certain versions before all related patents expire, but it depends on the specific patent landscape and how broadly any remaining patents cover:
- Some patents cover formulation, manufacturing process, or specific dosage strengths.
- A remaining patent could block approval for some competitors but not others (depending on what’s being changed in the generic).
That’s why the exact product and patent listing matters more than “glycopyrrolate” alone. [1]
What I need to give you an exact expiry date
Reply with:
1) Country/market (US, EU, UK, etc.)
2) Dosage form (tablets, injection, etc.)
3) Strength (if applicable)
4) Whether you mean patent expiry or regulatory exclusivity
5) (Optional) Brand name or reference product name you’re tracking
With that, I can point to the specific expiry date(s) for the relevant protected entries.
Sources:
[1] https://www.drugpatentwatch.com/?s=glycopyrrolate